CN105377303B - 口腔崩解片 - Google Patents

口腔崩解片 Download PDF

Info

Publication number
CN105377303B
CN105377303B CN201480032994.3A CN201480032994A CN105377303B CN 105377303 B CN105377303 B CN 105377303B CN 201480032994 A CN201480032994 A CN 201480032994A CN 105377303 B CN105377303 B CN 105377303B
Authority
CN
China
Prior art keywords
mass
tablet
oral disnitegration
disnitegration tablet
content
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201480032994.3A
Other languages
English (en)
Chinese (zh)
Other versions
CN105377303A (zh
Inventor
近藤真弘
落合直也
坂仓有纪
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanwa Kagaku Kenkyusho Co Ltd
Original Assignee
Sanwa Kagaku Kenkyusho Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanwa Kagaku Kenkyusho Co Ltd filed Critical Sanwa Kagaku Kenkyusho Co Ltd
Publication of CN105377303A publication Critical patent/CN105377303A/zh
Application granted granted Critical
Publication of CN105377303B publication Critical patent/CN105377303B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN201480032994.3A 2013-07-19 2014-07-17 口腔崩解片 Expired - Fee Related CN105377303B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2013150410 2013-07-19
JP2013-150410 2013-07-19
PCT/JP2014/069024 WO2015008825A1 (ja) 2013-07-19 2014-07-17 口腔内崩壊錠

Publications (2)

Publication Number Publication Date
CN105377303A CN105377303A (zh) 2016-03-02
CN105377303B true CN105377303B (zh) 2019-04-05

Family

ID=52346267

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201480032994.3A Expired - Fee Related CN105377303B (zh) 2013-07-19 2014-07-17 口腔崩解片

Country Status (6)

Country Link
US (1) US20160136091A1 (OSRAM)
EP (1) EP3023109A4 (OSRAM)
JP (2) JP5713421B1 (OSRAM)
KR (1) KR20160030093A (OSRAM)
CN (1) CN105377303B (OSRAM)
WO (1) WO2015008825A1 (OSRAM)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3021837A1 (en) * 2013-07-19 2016-05-25 Bayer Pharma Aktiengesellschaft Super quick disintegrating tablet formula for api miglitol
CN105943525A (zh) * 2016-06-02 2016-09-21 中国药科大学 一种保肝药物组合物
CN114432424B (zh) * 2021-12-27 2023-06-27 南通联亚药业股份有限公司 一种稳定的铝塑包装去氨加压素片剂
CN115813870B (zh) * 2022-12-21 2024-05-10 江苏吴中医药集团有限公司 卡络磺钠片及其制备方法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5292729A (en) * 1992-08-14 1994-03-08 Albion International, Inc. II-bond aromatic vitamin chelates
WO2001076565A1 (fr) 2000-04-12 2001-10-18 Banyu Pharmaceutical Co., Ltd. Compositions et preparations se desintegrant dans la cavite buccale
AU2001274575A1 (en) 2000-06-20 2002-01-02 Sanwa Kagaku Kenkyusho Co., Ltd. Nucleated molded article, method of producing the same, and device for producingthe same
JP4162405B2 (ja) 2000-12-28 2008-10-08 エーザイ・アール・アンド・ディー・マネジメント株式会社 鋳型錠
EP1430888A1 (en) 2001-09-28 2004-06-23 Sanwa Kagaku Kenkyusho Co., Ltd. Press-coated molded article undergoing quick disintegration
FR2834889B1 (fr) * 2002-01-18 2004-04-02 Roquette Freres Forme pharmaceutique solide orodispersible
JP5584509B2 (ja) 2003-02-28 2014-09-03 東和薬品株式会社 口腔内崩壊錠剤
JP4551627B2 (ja) 2003-02-28 2010-09-29 東和薬品株式会社 口腔内崩壊錠剤の製造方法
JP5062871B2 (ja) 2003-05-13 2012-10-31 東和薬品株式会社 苦味を低減した口腔内崩壊錠剤
JP5062872B2 (ja) 2003-08-13 2012-10-31 東和薬品株式会社 不快な味を低減した口腔内崩壊錠剤
JP3841804B2 (ja) * 2003-10-15 2006-11-08 富士化学工業株式会社 口腔内速崩壊性錠剤用の組成物
CN1615862A (zh) * 2003-11-10 2005-05-18 浙江医药股份有限公司新昌制药厂 一种治疗ⅱ型糖尿病的米格列醇口腔崩解片及其制备方法
JP2005187349A (ja) * 2003-12-24 2005-07-14 Lion Corp 口腔内崩壊錠
JP3996626B2 (ja) 2004-06-22 2007-10-24 塩野義製薬株式会社 口腔内速崩壊錠
JP4446177B2 (ja) 2005-01-21 2010-04-07 東和薬品株式会社 耐湿性口腔内崩壊錠の製造方法
WO2006087629A2 (en) * 2005-02-21 2006-08-24 Aurobindo Pharma Limited Rapidly disintegrating composition of olanzapine
JP5535616B2 (ja) 2006-03-31 2014-07-02 ルビコン リサーチ プライベート リミテッド 口腔内崩壊錠剤のための直接圧縮性複合材
EP2572705B1 (en) 2007-10-01 2017-09-13 Laboratorios Lesvi, S.L. Orodispersible tablets
EP2218443B1 (en) 2007-11-21 2014-03-26 Dainippon Sumitomo Pharma Co., Ltd. Orally disintegrating tablet
KR20100096140A (ko) 2007-12-08 2010-09-01 바이엘 쉐링 파마 악티엔게젤샤프트 경구 분산성 정제
EP2262487A2 (en) 2008-02-29 2010-12-22 Otsuka Pharmaceutical Co., Ltd. An orally disintegrating tablet of cilostazol
CN102300563A (zh) * 2009-01-29 2011-12-28 大日本住友制药株式会社 具有内核的口腔崩解片剂
WO2010122583A2 (en) * 2009-04-24 2010-10-28 Rubicon Research Private Limited Oral pharmaceutical compositions of acid labile substances
US8920839B2 (en) 2009-05-20 2014-12-30 Sumitomo Dainippon Pharma Co., Ltd. Dry-coated orally-disintegrating tablet
WO2010134574A1 (ja) 2009-05-20 2010-11-25 大日本住友製薬株式会社 口腔内崩壊錠
WO2011019045A1 (ja) * 2009-08-11 2011-02-17 富士化学工業株式会社 崩壊性粒子組成物及び口腔内速崩壊錠
EP2465540B1 (en) * 2009-08-11 2016-10-05 Fuji Chemical Industry Co., Ltd. Disintegrating particle composition and orally rapidly disintegrating tablet
KR101907218B1 (ko) 2009-12-11 2018-10-11 다이닛본 스미토모 세이야꾸 가부시끼가이샤 유핵형 구강내 붕해 정제
JPWO2012001977A1 (ja) * 2010-06-29 2013-08-22 富士化学工業株式会社 崩壊性組成物及び易崩壊性圧縮成型物
JP2012197245A (ja) * 2011-03-22 2012-10-18 Kowa Co 新規な口腔内崩壊錠

Also Published As

Publication number Publication date
JP2015129175A (ja) 2015-07-16
EP3023109A4 (en) 2017-01-04
JP5713421B1 (ja) 2015-05-07
EP3023109A1 (en) 2016-05-25
KR20160030093A (ko) 2016-03-16
HK1220139A1 (zh) 2017-04-28
JPWO2015008825A1 (ja) 2017-03-02
CN105377303A (zh) 2016-03-02
US20160136091A1 (en) 2016-05-19
WO2015008825A1 (ja) 2015-01-22

Similar Documents

Publication Publication Date Title
KR101682965B1 (ko) 구강내 붕괴성 피복 정제
JP5053865B2 (ja) 口腔内崩壊性固形製剤の製造法
JP4707073B2 (ja) アトルバスタチン経口投与用粒子状医薬組成物
JP5215172B2 (ja) 乾式直打速崩壊性錠剤
KR20100121509A (ko) 구강 내 붕괴정
WO2009096560A1 (ja) イミダフェナシン含有口腔内速崩壊性錠剤
JP2008280351A (ja) テルビナフィンを含有する医薬組成物およびその使用
EP3556345A1 (en) Orally disintegrated tablet comprising carbamate compound
CN105377303B (zh) 口腔崩解片
EP1757271A1 (en) Solid pharmaceutical preparation with improved stability and process for producing the same
ES2700364T3 (es) Comprimido de disgregación oral y método para su fabricación
EP2745848B1 (en) Orally disintegrating tablet containing hydroxyalkyl cellulose fine particles
JP2018118966A (ja) ３位が置換されたγ−アミノ酪酸誘導体を含有する圧縮固形医薬組成物。
KR20130097091A (ko) 구강 내 붕괴 정제
WO2013115743A1 (en) Effervescent tablet formulations comprising the combination of voglibose and metformin
US20130251793A1 (en) Pharmaceutical composition comprising phentermine and topiramate
JP2014114263A (ja) 口腔内速崩性錠剤
EP3088002A1 (en) Extended release formulation
HK1220139B (zh) 口腔崩解片
JP5690972B2 (ja) 酸化チタンの変色が抑制された組成物
EP4260847A1 (en) Timed-elution masking particles and oral pharmaceutical composition containing same
JP6150564B2 (ja) 口腔内速崩壊性錠剤
HK40053086A (en) Coating method
KR20090113776A (ko) 경구 고형 조성물
SAJJA FORMULATION AND IN-VITRO EVALUATION OF ORALLY ADMINISTERED GASTRO-RETENTIVE FLOATING TABLETS OF IMATINIB

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1220139

Country of ref document: HK

GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20190405

Termination date: 20200717

CF01 Termination of patent right due to non-payment of annual fee